2009-02-19Zeitschriftenartikel DOI: 10.1007/s00415-009-0149-2
Epidemiology of vertigo, migraine and vestibular migraine
Both migraine and vertigo are common in the general population with lifetime prevalences of about 16 % for migraine and 7 % for vertigo. Therefore, a concurrence of the two conditions can be expected in about 1.1 % of the general population by chance alone. However, recent epidemiological evidence suggests that the actual comorbidity is higher, namely 3.2 %. This can be explained by the fact that several dizziness and vertigo syndromes occur more frequently in migraineurs than in controls including benign paroxysmal positional vertigo, Meniere’s disease, motion sickness, cerebellar disorders and anxiety syndromes which may present with dizziness. In addition, there is increasing recognition of a syndrome called vestibular migraine (VM), which is vertigo directly caused by migraine. VM affects more than 1 % of the general population, about 10 % of patients in dizziness clinics and at least 9 % of patients in migraine clinics. Clinically, VM presents with attacks of spontaneous or positional vertigo lasting seconds to days. Migrainous accompaniments such as headache, phonophobia, photophobia or auras are common but not mandatory. Cochlear symptoms may be associated but are mostly mild and non-progressive. During acute attacks one may find central spontaneous or positional nystagmus and, less commonly, unilateral vestibular hypofunction. In the symptom-free interval, vestibular testing adds little to the diagnosis as findings are mostly minor and non-specific. In the absence of controlled studies, treatment of VM is adopted from the migraine sphere comprising avoidance of triggers, stress management as well as pharmacotherapy for acute attacks and prophylaxis.
Dateien zu dieser Publikation
Anzeige der Publikationen mit ähnlichem Titel, Autor, Urheber und Thema.
2014-04-10ZeitschriftenartikelResults of surveillance for infections with Shiga toxinproducing Escherichia coli (STEC) of serotype O104:H4 after the large outbreak in Germany, July to December 2011 Frank, Christina; Milde-Busch, Astrid; Werber, DirkAfter the massive outbreak of infections with Shiga toxin-producing Escherichia coli (STEC) of serotype O104:H4 in Germany in the summer of 2011, post-outbreak surveillance for further infections with this type of STEC was ...
2015-08-27ZeitschriftenartikelTransmission patterns of human enterovirus 71 to, from and among European countries, 2003 to 2013 Hassel, C.; Mirand, A.; Lukashev, A.; Terletskaia-Ladwig, E.; Farkas, A.; Schuffenecker, I.; Diedrich, Sabine; Huemer, H. P.; Archimbaud, C.; Peigue-Lafeuille, H.; Henquell, C.; Bailly, J.Enterovirus 71 (EV-71) is involved in epidemics of hand, foot, and mouth disease (HFMD) and has been reported to occur with severe neurological complications in eastern and south-east Asia. In other geographical areas, the ...
2015-06-24ZeitschriftenartikelEbola Virus Disease Outbreak in Isiro, Democratic Republic of the Congo, 2012: Signs and Symptoms, Management and Outcomes Kratz, Thomas; Roddy, Paul; Oloma, Antoine Tshomba; Jeffs, Benjamin; Ciruelo, Diana Pou; Rosa, Olimpia de la; Borchert, MatthiasData collected during the 2012 Ebola virus disease (EVD) epidemic in the Democratic Republic of the Congo were analysed for clinical signs, symptoms and case fatality of EVD caused by Bundibugyo virus (BDBV), establishment ...